|Titre :||No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone (2017)|
|Auteurs :||J. D. JONES ; A. CAMPBELL ; V. E. METZ ; S. D. COMER|
|Type de document :||Article : Périodique|
|Dans :||Addictive Behaviors (Vol.71, August 2017)|
|Article en page(s) :||104-106|
|Discipline :||SHS (Sciences humaines et sociales / Humanities and social sciences)|
Thésaurus TOXIBASEHEROINE ; SURDOSE ; NALOXONE ; CONDUITE A RISQUE ; FORMATION ; USAGER ; REDUCTION DES RISQUES
Introduction: Some fear that distribution of naloxone to persons at risk of experiencing an opioid overdose may reduce the perceived negative consequences of drug use, leading to riskier patterns of use. This study assessed whether participation in naloxone/overdose training altered drug use frequency, quantity or severity among heroin users in and out of treatment.
Methods: Clinical interviews were performed assessing patterns of heroin and other drug use prior to, and at multiple timepoints after overdose education and naloxone training. This study compared baseline drug use to that at 1 and 3 months post training.
Results: Both current heroin users (n = 61) and former users in agonist maintenance (n = 69) typically showed decreases in heroin and polydrug use at both 1 and 3 months after training. The Addiction Severity Index drug composite score also decreased at follow up.
Conclusions: This analysis found no evidence of compensatory drug use following naloxone/overdose training among two groups of heroin users. These findings support the acceptance and expansion of naloxone distribution to at-risk populations and may assist in allaying concerns about the potential for unintended negative consequences on drug use.
Participation in naloxone/overdose training did not alter severity of drug use among heroin users.
Active heroin users and users in agonist maintenance decreased heroin and polydrug use after training.
The Addiction Severity Index drug composite score also decreased at 1 and 3-month follow up.
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||Division on Substance Use Disorders, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, NY, USA|